Scientific Sessions

Continuing Education Accreditation Statements

Download the Institute of Learning Mobile App to Claim CME/CE at the 85th Scientific Sessions

 App Store Google Play

For international attendees, a Certificate of Attendance will be available for download from the continuing education evaluation system. 

If you have any questions regarding Continuing Education, please contact professionaleducation@diabetes.org.

How to Claim CME/CE Credits

Get detailed instructions on how to claim your CME/CE credits

PDF   Video Instructions

View the Frequently Asked Questions for Claiming CME/CE Credits at the ADA’s 85th Scientific Sessions.

Accreditation Statements for Live Sessions

Target Audience

The Scientific Sessions offer comprehensive educational programming covering the latest in the field of diabetes. The program is designed for physicians, scientists, researchers, nurses, dietitians, pharmacists, psychologists, and other health care professionals. 

Learning Objectives

 At the conclusion of this activity, attendees will be able to:

  • Identify the ADA’s 2025 standards of care for classifying, diagnosing, preventing, and treating prediabetes and diabetes
  • Assess non-pharmacologic treatment options for individualizing treatment protocols for the management of hyperglycemia and hypoglycemia
  • Apply clinical decision-making tools to the assessment and treatment of diabetes-related complications 
  • Develop a more aggressive and effective physiological, psychological, and behavioral treatment plan for patients with diabetes
  • Cite the research into current, emerging, and novel therapies for type 1 and type 2 diabetes
  • Discuss proven education strategies for increasing the impact of diabetes education with individual patients
  • Interpret the latest findings in the areas of epidemiology, genetics, immunology, transplantation, and islet biology as they relate to diabetes
Image
jointly accredited provider logo

In support of improving patient care, the ADA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Image
IPCE Credit logo

This activity was planned by and for the health care team, and learners will receive 29.5 interprofessional continuing education (IPCE) credits for learning and change.

Universal activity number for pharmacists: JA4008193-0000-25-009-L01-P

NOTE FOR PHARMACISTS: Upon closing the online evaluation, the ADA will upload the pharmacy-related CE information to CPE Monitor within 60 days. Per ACPE rules, the ADA does not have access nor the ability to upload credits requested after the evaluation closes. The last day to claim ACPE credits is August 18, 2025.

NOTE FOR PHYSICIANS: The ADA offers the AMA PRA Category 1 CME credit. This credit may be accepted by the American Board of Obesity Medicine Group. Two credits are earned for specific sessions related to obesity. Please request a copy of your transcript if you would like to submit it to ABOM. 

Physicians for ABIM Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables participants to earn up to 29.5 medical-knowledge-only MOC points in the American Board of Internal Medicine's (ABIM’s) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM-MOC credit.

NOTE: Upon submission of the online evaluation, MOC points will be immediately transferred to the ABIM. As stated above and per the ABIM rules, the ADA does not have access nor the ability to upload points requested after the evaluation closes. The last date to claim ABIM-MOC points is December 31, 2025.

Dietitians

The ADA is a Continuing Professional Education (CPE)-accredited provider with joint accreditation. Registered dietitian nutritionists (RDNs) and dietetic technicians registered (DTRs) will receive 29.5 continuing professional education units (CPEUs) for completion of this program/material. 

Physician Associates 

The ADA has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME criteria. This activity is designated for 29.5 AAPA Category 1 CME credits. PAs should only claim credits commensurate with the extent of their participation.

Psychologists

CE credits for psychologists are provided through the co-sponsorship of the American Psychological Association’s (APA’s) Office of Continuing Education in Psychology (CEP). The APA’s CEP office maintains responsibly for the content of the programs.

Social Workers

As a jointly accredited organization, the ADA is approved to offer social work CE by the Association of Social Work Boards (ASWB)-approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for CE credit. The ADA maintains responsibility for this course. Social workers completing this course receive 29.5 CE credits.

Certified Diabetes Care and Education Specialists

To satisfy the requirement for renewal of certification by continuing education for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE’s list of approved providers. The CBDCE does not approve CE. The ADA is on the CBDCE’s list of approved providers.

Content Validation Statements

  • All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.

AND/OR

All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Planning Committee Disclosures

Halis Akturk, MD
Disclosures: Consultant; Dexcom, Inc., Medtronic, Tandem Diabetes Care, Inc, Novo Nordisk. Research Support; Dexcom, Inc., Medtronic, Tandem Diabetes Care, Inc, Novo Nordisk.

Mark Atkinson, PhD
Disclosures: Advisory Panel; Imcyse. Board Member; Diamyd, Sanofi. Consultant; Abeta, Acto Bio Therapeutics, CodeBio, Diamyd, Endsulin, Forkhead Biotherapeutics, Inspira Therapeutics, Janssen Pharmaceuticals, Inc, Nirmindas, Provention Bio, Inc, Provention Bio, Inc, Microbion, Microbion, Quell, Repertoire, Novo Nordisk. Speaker's Bureau; Provention Bio, Inc, Provention Bio, Inc, Microbion, Microbion, Sanofi, Vertex Pharmaceuticals Incorporated. Stock/Shareholder; Diamyd, Endsulin, IM Therapeutics.

Gretchen Benson, RDN, CDCES
Disclosures: None.

Elizabeth Beverly, PhD
Disclosures: None.

Eda Cengiz, MD, MHS
Disclosures: Advisory Panel; Novo Nordisk, Arecor Therapeutics, Eli Lilly and Company, Tandem Diabetes Care, Inc, Portal Insulin, MannKind Corporation.

Laura den Hartigh, PhD
Disclosures: None.

Rajesh Garg, MD
Disclosures: None.

Rebecca Hauesler, PhD
Disclosures: None.

Rita Rastogi Kalyani, MD, MHS
Disclosures: None.

Young-Bum Kim, PhD
Disclosures: None.

Teresa Mastracci, PhD
Disclosures: None.

Leigh Perreault, MD
Disclosures: Advisory Panel; Novo Nordisk, Eli Lilly and Company, Boehringer-Ingelheim. Speaker's Bureau; Novo Nordisk, Eli Lilly and Company, Boehringer-Ingelheim.

Priya Prahalad, MD, PhD
Disclosures: Consultant; Sanofi.

Holger Russ, PhD
Disclosures: Advisory Panel; Tolerance Bio. Consultant; Axon Advisors, Guidepoint Consulting, Tolerance Bio. Research Support; Tolerance Bio.

Ellen Schur, MD, MS
Disclosures: Consultant; Amgen Inc.

Cassandra Spracklen, PhD
Disclosures: None.

Paul Titchenell, PhD
Disclosures: Consultant; Pfizer Inc, Unnatural Products Inc., Supercede, Pioneering Medicines, Boehringer-Ingelheim, Alnylam, OrsoBio.

Lynn Ang, MD
Disclosures: None.

Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES
Disclosures: Speaker's Bureau; Abbott Diagnostics, MannKind Corporation, Sanofi, Ascensia Diabetes Care. Consultant; Medtronic, Ascensia Diabetes Care. Board Member; Ohio ADCES.

Maria Bettini, PhD
Disclosures: None.

Alejandro Caicedo, PhD
Disclosures: None.

Jenny DeJesus, DNP, ANP, BC-ADM
Disclosures: None.

Sagar Dugani, MD, PhD, MPH
Disclosures: None.

Manami Hara, DDS, PhD
Disclosures: None.

Janice Hwang, MD, MHS
Disclosures: None.

Amanda Killeen, DPM
Disclosures: Advisory Panel; GMS Holding, Caleres, Inc.

Rebecca Longo, MSN, ACNP-BC, CDCES
Disclosures: Advisory Panel; Dexcom, Inc.

Rozalina McCoy, MD, MS
Disclosures: Consultant; Wolters Kluwer Health, Yale New Haven Health System. Research Support; American Diabetes Association. Other Relationship; American Diabetes Association.

Camille Powe, MD
Disclosures: Research Support; Dexcom, Inc.. Other Relationship; Mediflix, Wolters Kluwer Health.

Michael Riddell, PhD
Disclosures: Advisory Panel; Zucara Therapeutics, embecta. Consultant; Dexcom, Inc., Insulet Corporation, Eli Lilly and Company, Novo Nordisk. Speaker's Bureau; Novo Nordisk, Dexcom, Inc., Sanofi, Eli Lilly and Company. Stock/Shareholder; Zucara Therapeutics. Research Support; Dexcom, Inc., Insulet Corporation, Eli Lilly and Company.

Jennifer Schaub, MD
Disclosures: Consultant; Klick. Research Support; AstraZeneca, Roche Genetech, Novo Nordisk, Eli Lilly and Company.

Paolo Silva, MD
Disclosures: Research Support; Kubota Vision, Optos, Optomed.

Katrin Svensson, PhD
Disclosures: Research Support; Merck & Co., Inc. Other Relationship; Kyttaro.

Amisha Wallia, MD, MS
Disclosures: Research Support; UnitedHealth Group.